Sumitomo Mitsui Trust Group Inc. Raises Stock Holdings in Danaher Corporation $DHR

Key Points

• Sumitomo Mitsui Trust Group Inc. increased its stake in Danaher Corporation by 3.3% during Q2, owning approximately $407.66 million worth of shares after buying an additional 65,383 shares.
• Danaher reported $1.89 earnings per share (EPS) for the latest quarter, exceeding analysts' estimates, with revenue reaching $6.05 billion.
• The company recently announced a quarterly dividend of $0.32 per share, with an ex-dividend date on September 26, showing a 0.6% yield and a payout ratio of 27.23%.

Sumitomo Mitsui Trust Group Inc. increased its position in Danaher Corporation (NYSE:DHR - Free Report) by 3.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,063,672 shares of the conglomerate's stock after buying an additional 65,383 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned 0.29% of Danaher worth $407,658,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC boosted its holdings in Danaher by 22.2% in the first quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate's stock valued at $1,871,000 after acquiring an additional 1,660 shares in the last quarter. Pacific Capital Partners Ltd bought a new stake in Danaher in the first quarter valued at $7,175,000. GHP Investment Advisors Inc. boosted its holdings in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after acquiring an additional 99 shares in the last quarter. International Assets Investment Management LLC boosted its holdings in Danaher by 39.5% in the first quarter. International Assets Investment Management LLC now owns 2,191 shares of the conglomerate's stock valued at $449,000 after acquiring an additional 620 shares in the last quarter. Finally, Global Assets Advisory LLC bought a new stake in Danaher in the first quarter valued at $312,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of the business's stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 11.10% of the company's stock.

Danaher Stock Performance

Shares of Danaher stock opened at $224.34 on Friday. The stock has a market cap of $158.46 billion, a price-to-earnings ratio of 46.26, a PEG ratio of 3.31 and a beta of 0.77. The firm's 50-day moving average is $202.49 and its 200 day moving average is $198.02. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.22.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.72 by $0.17. The company had revenue of $6.05 billion for the quarter, compared to analysts' expectations of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. Danaher's revenue was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher's payout ratio is 27.23%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Weiss Ratings reiterated a "hold (c-)" rating on shares of Danaher in a report on Wednesday, October 8th. TD Cowen boosted their target price on shares of Danaher from $250.00 to $260.00 and gave the company a "buy" rating in a report on Wednesday. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a report on Tuesday, September 2nd. UBS Group dropped their target price on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. Finally, Barclays boosted their target price on shares of Danaher from $225.00 to $250.00 and gave the company an "overweight" rating in a report on Wednesday. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, Danaher has a consensus rating of "Moderate Buy" and a consensus target price of $243.39.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.